logo

Equity Analysis

Company Profile
Detailed Quotes

Company News

    Zydus Lifesciences Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    532321
    INE010B01027
    177.8674103
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    ZYDUSLIFE
    20.37
    89061.77
    EPS(TTM)
    Face Value()
    Div & Yield %:
    43.46
    1
    0.34
     
Odyssey Corporation consolidated net profit declines 50.00% in the December 2024 quarter
Feb 12,2025
Net profit of Odyssey Corporation declined 50.00% to Rs 0.12 crore in the quarter ended December 2024 as against Rs 0.24 crore during the previous quarter ended December 2023. Sales rose 152.18% to Rs 13.87 crore in the quarter ended December 2024 as against Rs 5.50 crore during the previous quarter ended December 2023.

ParticularsQuarter Ended
Dec. 2024Dec. 2023% Var.
Sales13.875.50 152
OPM %-3.39-8.73 -
PBDT0.360.59 -39
PBT0.240.54 -56
NP0.120.24 -50